Literature DB >> 9263174

IL-10 plasma levels correlate with disease activity in spondyloarthropathy.

P Claudepierre, J C Rymer, X Chevalier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9263174

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  10 in total

1.  Flow cytometric analysis of gut mucosal lymphocytes supports an impaired Th1 cytokine profile in spondyloarthropathy.

Authors:  N Van Damme; M De Vos; D Baeten; P Demetter; H Mielants; G Verbruggen; C Cuvelier; E M Veys; F De Keyser
Journal:  Ann Rheum Dis       Date:  2001-05       Impact factor: 19.103

Review 2.  Th2 mediated regulation in RA and the spondyloarthropathies.

Authors:  J A G van Roon; J W J Bijlsma
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

3.  Preferential type 1 chemokine receptors and cytokine production of CD28- T cells in ankylosing spondylitis.

Authors:  C Duftner; C Dejaco; W Kullich; A Klauser; C Goldberger; A Falkenbach; M Schirmer
Journal:  Ann Rheum Dis       Date:  2005-10-11       Impact factor: 19.103

4.  Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor alpha in two patients with early disease and transforming growth factor beta in three more advanced cases.

Authors:  R J François; L Neure; J Sieper; J Braun
Journal:  Ann Rheum Dis       Date:  2005-10-25       Impact factor: 19.103

5.  Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFalpha.

Authors:  D Baeten; N Van Damme; F Van den Bosch; E Kruithof; M De Vos; H Mielants; E M Veys; F De Keyser
Journal:  Ann Rheum Dis       Date:  2001-08       Impact factor: 19.103

Review 6.  Cytokines and the immunopathology of the spondyloarthropathies.

Authors:  J Braun; J Sieper
Journal:  Curr Rheumatol Rep       Date:  1999-10       Impact factor: 4.592

7.  Increased CCR4 expression on circulating CD4(+) T cells in ankylosing spondylitis, rheumatoid arthritis and systemic lupus erythematosus.

Authors:  P T Yang; H Kasai; L J Zhao; W G Xiao; F Tanabe; M Ito
Journal:  Clin Exp Immunol       Date:  2004-11       Impact factor: 4.330

Review 8.  Cytokines in the seronegative spondyloarthropathies and their modification by TNF blockade: a brief report and literature review.

Authors:  C Keller; A Webb; J Davis
Journal:  Ann Rheum Dis       Date:  2003-12       Impact factor: 19.103

Review 9.  Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-alpha therapy and other novel approaches.

Authors:  Juergen Braun; Joachim Sieper
Journal:  Arthritis Res       Date:  2002-08-06

10.  Increase In Il-31 Serum Levels Is Associated With Reduced Structural Damage In Early Axial Spondyloarthritis.

Authors:  Nicolas Rosine; Adrien Etcheto; Houria Hendel-Chavez; Raphaèle Seror; Karine Briot; Anna Molto; Philippe Chanson; Yassine Taoufik; Daniel Wendling; Rik Lories; Francis Berenbaum; Rosaline van den Berg; Pascal Claudepierre; Antoine Feydy; Maxime Dougados; Christian Roux; Corinne Miceli-Richard
Journal:  Sci Rep       Date:  2018-05-16       Impact factor: 4.379
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.